The Nutshell

» policy, cancer and disease/medicine

Daily News Roundup

Most Recent

image: Henrietta Lacks’s Family Seeks Compensation

Henrietta Lacks’s Family Seeks Compensation

By | February 16, 2017

Family members of Lacks, the donor behind the widely used HeLa cell line, are planning to sue Johns Hopkins University.

0 Comments

image: USDA Removes Animal Welfare Data From Public Website

USDA Removes Animal Welfare Data From Public Website

By | February 7, 2017

Due to privacy concerns, the US Department of Agriculture will no longer make animal welfare inspection reports and enforcement records public.

0 Comments

image: Regulators OK Clinical Trials Using Donor Stem Cells

Regulators OK Clinical Trials Using Donor Stem Cells

By | February 6, 2017

Japanese health officials approve human experiments to treat macular degeneration with a cell therapy derived from induced pluripotent stem cells.

0 Comments

The tumor biologist’s landmark discovery provided the first clear evidence that genetic mutations could lead to cancer, and gave rise to a crucial cancer drug.

0 Comments

Oncologists have raised concerns about a mouse study that suggests the vaccine for human papillomavirus could cause brain damage.

0 Comments

image: Mouse Immunology Paper Retracted

Mouse Immunology Paper Retracted

By | December 16, 2016

A finding of misconduct spurs the retraction of a Science paper claiming to have identified a protein in mice that boosted immunity to both viruses and cancer.

1 Comment

image: MD Anderson Cancer Center’s Losses Grow

MD Anderson Cancer Center’s Losses Grow

By | December 13, 2016

The first two months of the fiscal year saw $102.4 million in operating losses.

1 Comment

In a pair of clinical studies of psilocybin, the active ingredient in magic mushrooms, participants reported positive changes to their moods and outlooks.

1 Comment

image: First CRISPR Clinical Trial Commences

First CRISPR Clinical Trial Commences

By | November 15, 2016

Scientists in China aim to treat 10 people with lung cancer with CRISPR-edited cells.

0 Comments

image: Amyloid Designed to Inactivate Cancer-Related Protein

Amyloid Designed to Inactivate Cancer-Related Protein

By | November 14, 2016

Researchers build a peptide that causes a receptor to form toxic, amyloid-like clumps in cells.

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

  4. Abundant Sequence Errors in Public Databases
Business Birmingham